TORONTO, ON--(Marketwired - Oct 28, 2013) - Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company, is pleased to announce Axxess Pharma (AXXE) and TapouT have signed an agreement providing Axxess Pharma the world-wide exclusive rights, to develop, market and sell a line of pain relief and muscle recovery products, as well as develop and market a vitamins and minerals line under the TapouT brand name.
"This is an amazing accomplishment for Axxess to align itself with a world-class sporting brand, and we will focus our efforts to ensure success," said Dr. Daniel Bagi, President of Axxess Pharma Inc. "There are six products, ready to launch and we anticipate TapouT and AXXE will mutually benefit tremendously from this alliance, as we recognize the power of the TapouT brand. This agreement will be a major priority to our Company and anticipated to generate strong global sales."
Since previously announcing the MOU, Axxess has had strong interest from several large overseas companies to market and sell its TapouT line of products in Europe, Asia and Australia. Axxess intends to aggressively market its line of premium all-natural pain-relief products world-wide. The TapouT brand is highly recognizable, especially in Asia and Brazil. Through TapouT's sponsorship of UFC events, Axxess plans to piggyback on its strong brand awareness and substantial loyal customer base. A second wave of TapouT branded products will be a premium vitamins line and Axxess has already begun talks with a Canadian cGMP (current Good Manufacturing Practices) manufacturer, anticipate launching in late 2013.
"We will be launching in both retail and through a well-planned on-line sales strategy through our AllStar Health Brands subsidiary," Bagi further stated.
"We pride ourselves in partnering with companies that understand the brand DNA, have the right products and methods to market and distribute," said Nick Woodhouse, President and Chief Marketing Officer at Authentic Brands Group, LLC, brand owners of TapouT. "We anticipate a long-term relationship and look forward to working with the team at Axxess to provide incredible pain relief formulas to TapouT customers across the world."
To view a video of the six products ready to launch under the TapOut brand, existing products and management, please click on the video link: https://www.youtube.com/watch?v=IfdFiNelN3c
For more information, please visit www.axxesspharmainc.com, or contact Investor Relations at (973) 351-3868.
About Axxess Pharma Inc.:
Axxess Pharma Inc. is a Nevada Corporation operating through its wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain, - to optimal health management through improved nutritional supplements.
Founded in 1997, TapouT was the first apparel brand to represent the sport of MMA. Since then, TapouT has become synonymous with high performance athletics and training, becoming a globally recognized sporting goods brand. Its mantra, "My Fight Matters" has expanded the brand to celebrate athletes and fans alike who wear TapouT as a badge of honor symbolizing the brand's never quit spirit and attitude.
In 2010, TapouT was purchased by ABG TapouT, LLC a division of Authentic Brands Group, LLC and has since expanded the brand globally with licensees throughout North America, South America, Australia, South Africa, UK and Europe. Product categories include apparel and accessories, training and safety equipment, footwear, eyewear, timepieces, beverages, personal care and more. For more information, please visit www.tapout.com or www.abg-nyc.com.
About Authentic Brands Group, LLC
Authentic Brands Group, in partnership with Leonard Green & Partners, is an intellectual property corporation with a mandate to acquire, manage and build long-term value in prominent consumer brands. Headquartered in New York City, ABG's mission is to further enhancebrand equity through partnering with best-in-class licensees and direct-to-retail partnerships. ABG brands include Marilyn Monroe®, Juicy Couture®, Judith Leiber®, Adrienne Vittadini®, Taryn Rose®, Hickey Freeman®, Hart Schaffner Marx®, Palm Beach®, Misook®, Prince®, Spyder®, Ektelon®, Viking®, Bobby Jones®, TapouT®, Sportcraft®. www.abg-nyc.com.
Safe Harbor Statement:
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.
The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.